Oxford Asset Management’s Atea Pharmaceuticals AVIR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$147K	Buy	40,787 +18,585	+84%	+$66.9K	0.05%	431
2025 Q1	$66.4K	Buy	+22,202	New	+$66.4K	0.03%	433
2024 Q4	–	Sell	-10,912	Closed	-$36.6K	–	450
2024 Q3	$36.6K	Buy	+10,912	New	+$36.6K	0.03%	292